Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.

Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.

Regulatory T cells (T(regs)) manipulated ex vivo have potential as cellular therapeutics in autoimmunity and transplantation. Although it is possible to expand naturally occurring T(regs), an attractive alternative possibility, particularly suited to solid organ and bone marrow transplantation, is t...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Feng, G, Nadig, SN, Bäckdahl, L, Beck, S, Francis, R, Schiopu, A, Whatcott, A, Wood, K, Bushell, A
Format:	Journal article
Sprache:	English
Veröffentlicht:	2011

Ähnliche Einträge

Cyclic nucleotide phosphodiesterases in health and disease /
von: Beavo, Joe, et al.
Veröffentlicht: (2007)

Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
von: Issa, F, et al.
Veröffentlicht: (2010)

A brief in vitro activation is sufficient to equip naturally-occurring regulatory T Cells to control allograft rejection long-term
von: Chan, T, et al.
Veröffentlicht: (2014)

Cyclic nucleotide specific phosphodiesterases of <it>Leishmania major</it>
von: Linder Markus, et al.
Veröffentlicht: (2006-03-01)

Role of Cyclic Nucleotide Phosphodiesterases in Inner Ear and Hearing
von: Rahul Mittal, et al.
Veröffentlicht: (2017-11-01)

The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis
von: Peter B. Snyder, et al.
Veröffentlicht: (2005-03-01)

CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
von: Steger, U, et al.
Veröffentlicht: (2006)

Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition.
von: Threlfell, S, et al.
Veröffentlicht: (2013)

The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen.
von: Bushell, A, et al.
Veröffentlicht: (2005)

Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
von: Hester, J, et al.
Veröffentlicht: (2012)

Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
von: Hester, J, et al.
Veröffentlicht: (2012)

Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection.
von: Moore, C, et al.
Veröffentlicht: (2015)

Harnessing regulatory t cells for clinical use in transplantation: The end of the beginning
von: Juvet, S, et al.
Veröffentlicht: (2014)

Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.
von: Juvet, S, et al.
Veröffentlicht: (2014)

Modulation of compartmentalized cyclic nucleotide signalling via local inhibition of phosphodiesterase activity
von: Brescia, M, et al.
Veröffentlicht: (2016)

Phosphodiesterases maintain signaling fidelity via compartmentalization of cyclic nucleotides.
von: Lomas, O, et al.
Veröffentlicht: (2014)

Editorial: Cyclic nucleotide phosphodiesterases (PDEs) signaling in the endocrine system
von: Federica Campolo, et al.
Veröffentlicht: (2025-01-01)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
von: Stepan Gambaryan, et al.
Veröffentlicht: (2023-08-01)

Editorial: Cyclic Nucleotide Phosphodiesterases (PDEs) in Immune Regulation and Inflammation
von: Stefan Brocke, et al.
Veröffentlicht: (2022-07-01)

Expression and regulation of cyclic nucleotide phosphodiesterases in human and rat pancreatic islets.
von: Emilia Heimann, et al.
Veröffentlicht: (2010-01-01)

Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
von: Feng, G, et al.
Veröffentlicht: (2008)

2',3'-cyclic nucleotide 3'-phosphodiesterases inhibit hepatitis B virus replication.
von: Hui Ma, et al.
Veröffentlicht: (2013-01-01)

Apicomplexan phosphodiesterases in cyclic nucleotide turnover: conservation, function, and therapeutic potential
von: William J. Moss, et al.
Veröffentlicht: (2024-02-01)

Regulatory T Cells in the Immunodiagnosis and Outcome of Kidney Allograft Rejection
von: O. Franzese, et al.
Veröffentlicht: (2013-01-01)

CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis.
von: Warnecke, G, et al.
Veröffentlicht: (2010)

CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation.
von: Karim, M, et al.
Veröffentlicht: (2005)

Effector and Regulatory T Cell Trafficking in Corneal Allograft Rejection
von: Afsaneh Amouzegar, et al.
Veröffentlicht: (2017-01-01)

Identification of gene markers for the prediction of allograft rejection or permanent acceptance.
von: Sawitzki, B, et al.
Veröffentlicht: (2007)

Pre-synaptic sympathetic calcium channels, cyclic nucleotide-coupled phosphodiesterases and cardiac excitability
von: Li, D, et al.
Veröffentlicht: (2019)

Identification and Localization of the Cyclic Nucleotide Phosphodiesterase 10A in Bovine Testis and Mature Spermatozoa.
von: Serge Goupil, et al.
Veröffentlicht: (2016-01-01)

Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation.
von: Bäckdahl, L, et al.
Veröffentlicht: (2009)

In vivo generated CD25(+)CD4(+) T cells regulate islet allograft rejection by preventing effector cell migration into the graft
von: Bortecen, K, et al.
Veröffentlicht: (2005)

The Role of Regulatory Myeloid Cell Therapy in Renal Allograft Rejection
von: Jingming Zhuang, et al.
Veröffentlicht: (2021-02-01)

GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function.
von: Bushell, A, et al.
Veröffentlicht: (2007)

Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A
von: Susann Schröder, et al.
Veröffentlicht: (2018-03-01)

Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease.
von: Michael Weber, et al.
Veröffentlicht: (2013-01-01)

Multiplicity of Glucocorticoid Action in Inhibiting Allograft Rejection
von: Wassim Y. Almawi, et al.
Veröffentlicht: (1998-11-01)

CD44 Blockade Generates Functional iTreg In Vitro By Reducing Memory T Cell IL-6 Production
von: Whatcott, A, et al.
Veröffentlicht: (2014)

CD44 Blockade Generates Functional iTreg In Vitro By Reducing Memory T Cell IL-6 Production.
von: Whatcott, A, et al.
Veröffentlicht: (2014)

iPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells
von: Songjie Cai, et al.
Veröffentlicht: (2017-05-01)